Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas

Stopped early

Conditions studied: Parathyroid Neoplasm, Parathyroid Diseases

In brief

The purpose of this study is to design a method to better localize parathyroid adenomas. This study will include approximately 6 patients who have not had surgery and another 25 patients who have already had surgery over the course of one year.

Key facts

Study ID

NCT00639405

Run by

State University of New York - Upstate Medical University

People needed

12

Starts

2005-09-01

Expected to finish

2008-08-01

Last updated by the study team

2011-04-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are 18 years and over
• subjects who have had a failed parathyroidectomy and now presents with persistent hyperparathyroidism or recurrent hyperparathyroidism
• 6 control patients with parathyroid adenomas who have not yet had surgery will be selected to test the efficacy of the software.

You may not qualify if…

• Potential female subjects who are pregnant
• Any potential subject who has an implanted metallic device, stent or staples
• any subject weighing 300lb

Where it is running

• SUNY Upstate Medical University — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.